Drug Discovery and Evaluation

Author: Hans G. Vogel
Publisher: Springer Science & Business Media
ISBN: 366203333X
Format: PDF, Mobi
Download Now
This reference book contains a comprehensive selection of the most frequently used assays for reliably detecting pharmacological effects of potential drugs, including tests for cardiovascular, analgesic, psychotropic, metabolic, endocrine, respiratory, renal, and immunomodulatory activities. Each of the over 700 assays comprises a detailed protocol with the purpose and rationale of the method, a description of the experimental procedure, a critical assessment of the results and their pharmacological and clinical relevance, and pertinent references. Identification of specific tests is facilitated by the enclosed CD-ROM which allows for a quick and full text research. An appendix with guidelines and legal regulations for animal experiments in various countries will help to plan these experiments properly in accordance with the welfare of laboratory animals.

Drug Discovery and Evaluation Methods in Clinical Pharmacology

Author: H.Gerhard Vogel
Publisher: Springer Science & Business Media
ISBN: 3540898905
Format: PDF, ePub, Docs
Download Now
Drug Discovery and Evaluation has become a more and more difficult, expensive and time-consuming process. The effect of a new compound has to be detected by in vitro and in vivo methods of pharmacology. The activity spectrum and the potency compared to existing drugs have to be determined. As these processes can be divided up stepwise we have designed a book series "Drug Discovery and Evaluation" in the form of a recommendation document. The methods to detect drug targets are described in the first volume of this series "Pharmacological Assays" comprising classical methods as well as new technologies. Before going to man, the most suitable compound has to be selected by pharmacokinetic studies and experiments in toxicology. These preclinical methods are described in the second volume „Safety and Pharmacokinetic Assays". Only then are first studies in human beings allowed. Special rules are established for Phase I studies. Clinical pharmacokinetics are performed in parallel with human studies on tolerability and therapeutic effects. Special studies according to various populations and different therapeutic indications are necessary. These items are covered in the third volume: „Methods in Clinical Pharmacology".

Drug Discovery and Evaluation Pharmacological Assays

Author: Franz J. Hock
Publisher: Springer
ISBN: 9783319053912
Format: PDF, ePub
Download Now
The 4th edition of this successful reference book contains an updated selection of the most frequently used assays for reliably detecting the pharmacological effects of potential drugs. Effects covered include cardiovascular, analgesic, endocrine, psychotropic, respiratory, renal and immunomodulatory activities. Each of the more than 1,000 assays comprises a detailed protocol outlining the purpose and rationale of the method, a critical assessment of the results and their pharmacological and clinical relevance. In addition, animal models of rare diseases are described. For this 4th edition, all existing chapters have been revised and completely updated. A large number of assays were added. Sections that have been specifically enlarged include - Pharmacological assays in thrombosis and haemostasis, - Antidiabetic activity (includes completely new chapters such as Biochemical Methods in Diabetology), - Anti-atherosclerotic activity. New chapters are added such as Auditory Pharmacology, Oncology Activity, Stem Cells, Omics, Personalized Medicine, etc.

Drug Discovery and Evaluation

Author: H. Gerhard Vogel
Publisher: Springer Science & Business Media
ISBN: 9783540256380
Format: PDF
Download Now
This book is a landmark in the continuously changing world of drugs. It is essential reading for scientists and managers in the pharmaceutical industry who are involved in drug finding, drug development and decision making in the development process.

Drug Discovery and Evaluation Safety and Pharmacokinetic Assays

Author: H. Gerhard Vogel
Publisher: Springer
ISBN: 9783642252396
Format: PDF
Download Now
-A landmark in the continuously changing world of drugs -Essential reading for scientists and managers in the pharmaceutical industry involved in drug finding, drug development and decision making in the development process -Of use for government institutions and committees working on official guidelines for drug evaluation worldwide

Evaluation of Enzyme Inhibitors in Drug Discovery

Author: Robert A. Copeland
Publisher: John Wiley & Sons
ISBN: 111854028X
Format: PDF, ePub, Mobi
Download Now
Offers essential guidance for discovering and optimizingnovel drug therapies Using detailed examples, Evaluation of Enzyme Inhibitors inDrug Discovery equips researchers with the tools needed toapply the science of enzymology and biochemistry to the discovery,optimization, and preclinical development of drugs that work byinhibiting specific enzyme targets. Readers will applaud this bookfor its clear and practical presentations, including its expertadvice on best practices to follow and pitfalls to avoid. This Second Edition brings the book thoroughly up to datewith the latest research findings and practices. Updates exploreadditional forms of enzyme inhibition and special treatments forenzymes that act on macromolecular substrates. Readers will alsofind new discussions detailing the development and application ofthe concept of drug-target residence time. Evaluation of Enzyme Inhibitors in Drug Discovery beginsby explaining why enzymes are such important drug targets and thenexamines enzyme reaction mechanisms. The book covers: Reversible modes of inhibitor interactions with enzymes Assay considerations for compound library screening Lead optimization and structure-activity relationships forreversible inhibitors Slow binding and tight binding inhibitors Drug-target residence time Irreversible enzyme inactivators The book ends with a new chapter exploring the application ofquantitative biochemical principles to the pharmacologic evaluationof drug candidates during lead optimization and preclinicaldevelopment. The Second Edition of Evaluation of Enzyme Inhibitorsin Drug Discovery continues to offer a treatment of enzymologyapplied to drug discovery that is quantitative and mathematicallyrigorous. At the same time, the clear and simple presentationsdemystify the complex science of enzymology, making the bookaccessible to many fields— from pharmacology to medicinalchemistry to biophysics to clinical medicine.

Evaluation of Drug Candidates for Preclinical Development

Author: Chao Han
Publisher: John Wiley & Sons
ISBN: 9780470574881
Format: PDF, Kindle
Download Now
Emphasizes the integration of major areas of drug discovery and their importance in candidate evaluation It is believed that selecting the "right" drug candidate for development is the key to success. In the last decade, pharmaceutical R&D departments have integrated pharmacokinetics and drug metabolism, pharmaceutics, and toxicology into early drug discovery to improve the assessment of potential drug compounds. Now, Evaluation of Drug Candidates for Preclinical Development provides a complete view and understanding of why absorption-distribution-metabolism-excretion-toxicology (ADMET) plays a pivotal role in drug discovery and development. Encompassing the three major interrelated areas in which optimization and evaluation of drug developability is most critical—pharmacokinetics and drug metabolism, pharmaceutics, and safety assessment—this unique resource encourages integrated thinking in drug discovery. The contributors to this volume: Cover drug transporters, cytochrome P-450 and drug-drug interactions, plasma protein binding, stability, drug formulation, preclinical safety assessment, toxicology, and toxicokinetics Address developability issues that challenge pharma companies, moving beyond isolated experimental results Reveal connections between the key scientific areas that are critical for successful drug discovery and development Inspire forward-thinking strategies and decision-making processes in preclinical evaluation to maximize the potential of drug candidates to progress through development efficiently and meet the increasing demands of the marketplace Evaluation of Drug Candidates for Preclinical Development serves as an introductory reference for those new to the pharmaceutical industry and drug discovery in particular. It is especially well suited for scientists and management teams in small- to mid-sized pharmaceutical companies, as well as academic researchers and graduate students concerned with the practical aspects related to the evaluation of drug developability.

Drug Discovery Toxicology

Author: J. Eric McDuffie
Publisher: John Wiley & Sons
ISBN: 1119053331
Format: PDF, ePub, Mobi
Download Now
As a guide for pharmaceutical professionals to the issues and practices of drug discovery toxicology, this book integrates and reviews the strategy and application of tools and methods at each step of the drug discovery process. • Guides researchers as to what drug safety experiments are both practical and useful • Covers a variety of key topics – safety lead optimization, in vitro-in vivo translation, organ toxicology, ADME, animal models, biomarkers, and –omics tools • Describes what experiments are possible and useful and offers a view into the future, indicating key areas to watch for new predictive methods • Features contributions from firsthand industry experience, giving readers insight into the strategy and execution of predictive toxicology practices

Computational and Structural Approaches to Drug Discovery

Author: Robert M. Stroud
Publisher: Royal Society of Chemistry
ISBN: 0854043659
Format: PDF, Mobi
Download Now
This insightful book represents the experience and understanding of the global experts in the field and spotlights both the structural and medicinal chemistry aspects of drug design. The need to 'encode' the physiological factors of pharmacology, a key area, is explored.